Cost-effectiveness analysis of apixaban compared to low-molecularweight heparins and vitamin k antagonists for treatment and secondary prevention of venous thromboembolism

by Isabel Elías, Itziar Oyagüez, Luis Antonio Alvarez-Sala, Fernando García-Bragadoa, Andrés Navarro, Paloma González, Fernando de Andrés-Nogales, Javier Soto
Published 2016-05-01

Mutations in HFE and TFR2 genes in a Spanish patient with hemochromatosis Mutaciones en los genes HFE y TFR2 en un paciente español con hemocromatosis

by Alejandro del-Castillo-Rueda, Nuria Cuadrado-Grande, Emilio Álvarez-Fernández, Rafael Enríquez-de-Salamanca, Luis Antonio Álvarez-Sala, María Josefa Morán-Jiménez
Published 2011-07-01

Protective Effects of Cilastatin against Vancomycin-Induced Nephrotoxicity

by Blanca Humanes, Juan Carlos Jado, Sonia Camaño, Virginia López-Parra, Ana María Torres, Luís Antonio Álvarez-Sala, Emilia Cercenado, Alberto Tejedor, Alberto Lázaro
Published 2015-01-01

MR-Proadrenomedullin as biomarker of renal damage in urinary tract infection in children

by Rafael Peñalver Penedo, Marta Rupérez Lucas, Luis Antonio Álvarez-Sala Walther, Alicia Torregrosa Benavent, María Luisa Casas Losada, Luis Bañuelos Andrio, Ana Belén Rebolledo Poves, Mercedes Bueno Campaña
Published 2021-06-01

Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score

by Philippe Moulin, Robert Dufour, Maurizio Averna, Marcello Arca, Angelo B. Cefalù, Davide Noto, Laura D’Erasmo, Alessia Di Costanzo, Christophe Marçais, Luis Antonio Alvarez-Sala Walther, Maciej Banach, Jan Borén, Robert Cramb, Ioanna Gouni-Berthold, Elizabeth Hughes, Colin Johnson, Xavier Pintó, Željko Reiner, Jeanine Roeters van Lennep, Handrean Soran, Claudia Stefanutti, Erik Stroes, Eric Bruckert
Published 2018-12-01